One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
The complex cartography of cancer care
doi : 10.1016/S1470-2045(25)00229-3
Volume 26, Issue 5, May 2025, Page 529
Unlocking tumor-infiltrating lymphocyte potential with CRISPR-Cas9
Transrectal versus transperineal prostate biopsy: weighing the trade-offs
Lung cancer screening implementation: turning evidence into practice
Antimicrobial resistance: a problem across the cancer care continuum
The Global Platform for Access to Childhood Cancer Medicines: addressing inequities in childhood cancer care
Living within our means: trouble ahead for England's cancer planning
Shifting perspectives: a reflection on cancer-specific quality-of-life metrics in cancer care economics
Limitations in the meta-analysis of prostate radiotherapy-associated toxicity
Limitations in the meta-analysis of prostate radiotherapy-associated toxicity – Authors' reply
Meta-analysis on SBRT and ablation for localised RCC – Authors' reply
Correction to Lancet Oncol 2025: published online April 14. https://doi.org/10.1016/S1470-2045(25)00150
Carcinogenicity of automotive gasoline and some oxygenated gasoline additives
Experts aim to boost gynaecological cancer research in Australia and beyond
US National Firefighter Registry for Cancer shuts down amid layoffs
WHO reports health service disruptions due to suspensions of aid
Myung-Ju Ahn: battling sexism in medicine and supporting the next generation
Monstrosity of Tiny Tumours: an artist's journey through breast cancer
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial
Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study
Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial
Bortezomib, melphalan, and prednisone with or without daratumumab in transplant-ineligible patients with newly diagnosed multiple myeloma (ALCYONE): final analysis of an open-label, randomised, multicentre, phase 3 trial
Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort study
Incidence and prevalence of antimicrobial resistance in outpatients with cancer: a multicentre, retrospective, cohort study
Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trial
Clinical validation of droplet digital PCR assays in detecting BRAFV600-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD): a biomarker analysis from a double-blind, randomised phase 3 trial
Outcomes based on risk-adapted adjuvant therapy in postmenopausal women with early breast cancer: a nationwide, prospective cohort study by the Danish Breast Cancer Group
Antimicrobial resistance in patients with haematological malignancies: a scoping review
Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer
